CAS: 35302-72-8; 2,2,2-Trichloro-1-(1H-Pyrrol-2-yl)Ethanone

该化合物是一种有机化合物,其特点是有五人组成的含有氮的芳香异环,由五人组成,含有氮的热循环.三氯乙基苯基组的存在由于三氯乙基苯的电脱色性质而产生了重要的反应,这可能会影响该化合物的化学行为和稳定性.这种化合物一般没有颜色,可粉色黄色液体或固体,取决于其纯度和具体条件.它因其在有机合成中的潜在应用以及作为各种药品和农用化学品生产的中间体而闻名.三氯乙基苯基组可以参与核细胞替代反应,使其成为合成化学中的有用建筑块.此外,由于氯原子的存在,它可能表现出具体的环境和健康考虑,需要小心处理和储存.

结构式图片

相似化合物

72652-32-5 183268-72-6 72652-31-4

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    吡咯,三氯乙酰氯置于tea体系中,用 二氯甲烷 用作溶剂,化学反应 6.0H,以80%的收率获得2-(三氯乙酰)吡咯
    参考文献:新型吡咯并[2,1] [1,4]苯二氮卓-糖基化吡咯和咪唑聚酰胺共轭物的设计,合成和体外细胞毒性研究.
    标题:新型吡咯并[2,1] [1,4]苯二氮卓-糖基化吡咯和咪唑聚酰胺共轭物的设计,合成和体外细胞毒性研究.
    摘要:描述了新型吡咯并[2,1] [1,4]苯二氮杂-水不溶性31-38和水溶性39-46糖基化吡咯和咪唑聚酰胺共轭物的设计,合成和生物学评价,涉及氯化汞介导的相应环化反应氨基二乙基硫缩醛.为了提高pbd-聚酰胺共轭物的水溶性并探究最佳体外抗肿瘤活性的结构要求,制备了具有不同数量的含吡咯和咪唑的聚酰胺并掺入葡萄糖部分的化合物.这些化合物由美国国家癌症研究所针对60个人类癌细胞进行了测试,证明了水溶性pbd-聚酰胺化合物比现有的天然和合成吡咯并[2,1-C]具有更高的细胞毒性. 1,4]苯并二氮杂..这些化合物的乙酰化对应物水解后,其细胞毒性活性急剧增加.表1和表2中总结的活性数据表明,Pbd-聚酰胺的溶解度以及杂环的类型在影响pbd-聚酰胺缀合物的细胞毒性活性中起重要作用.与pbd-聚酰胺(水不溶型)结合物相比,Pbd-糖基化聚酰胺(水溶性)结合物39-46对许多人类癌细胞系具有高度的细胞毒性.
    Doi:10.1039/b306685A

    海关参考信息

    专利信息


    专利号:US-6683189-B1
    优先权日:1996-02-26
    标 题 :Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
    发明人:DERVAN PETER B; BAIRD ELDON
    权利人:CALIFORNIA INST OF TECHN
    摘要:The present invention describes a novel method for the solid phase synthesis of polyamides containing imidazole and pyrrole carboxamides. The polyamides are prepared on a solid support from aromatic carboxylic acids and aromatic amines with high stepwise coupling yields (>99%), providing milligram quantities of highly pure polyamides. The present invention also describes the synthesis of analogs of the natural products Netropsin and Distamycin A, two antiviral antibiotics. The present invention also describes a novel method for the solid phase synthesis of imidazole and pyrrole carboxamide polyamide-oligonucleotide conjugates. This methodology will greatly increase both the complexity and quantity of minor-groove binding polyamides and minor-groove binding polyamide-oligonucleotide conjugates which can be synthesized and tested.

    专利号:US-10919904-B2
    优先权日:2016-08-17
    标 题 :Northern-southern route to synthesis of bacteriochlorins
    发明人:LIU YIZHOU; LINDSEY JONATHAN S; ALLU SRINIVASA RAO; FUJITA HIKARU
    权利人:UNIV NORTH CAROLINA STATE
    摘要:Described herein are chlorins, bacteriochlorins, methods and intermediates for the synthesis of bacteriochlorins, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as luminescent compounds in flow cytometry, and as active agents in photodynamic therapy (PDT).

    专利号:US-RE49500-E
    优先权日:2004-05-14
    标 题:Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
    发明人:MARTINEZ BOTELLA GABRIEL; HALE MICHAEL; MALTAIS FRANCOIS; STRAUB JUDITH; TANG QING
    权利人:VERTEX PHARMA
    摘要:The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

    专利号:US-8981092-B2
    优先权日:2008-09-19
    标题 :Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity
    发明人:MIRIZZI DANILO; CERVI GIOVANNI; D ANELLO MATTEO; PAPEO GIANLUCA MARIANO ENRICO; FERGUSON RON; CASUSCELLI FRANCESCO
    权利人:MIRIZZI DANILO; CERVI GIOVANNI; D ANELLO MATTEO; PAPEO GIANLUCA MARIANO ENRICO; FERGUSON RON; CASUSCELLI FRANCESCO; NERVIANO MEDICAL SCIENCES SRL
    摘要:Compounds which are 4,7-disubstituted derivatives of 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one compounds, n nor pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, viral infection, prevention of AIDS development in HIV-infected individuals, cell proliferative disorders, autoimmune and neurodegenerative disorders; also disclosed is a process under Solid Phase Synthesis conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

    专利号:US-2019256521-A1
    优先权日:2016-08-17
    标题:Northern-southern route to synthesis of bacteriochlorins

    专利号:US-6545162-B1
    优先权日:1996-02-26
    标 题:Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
    常州市怡东化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yidongchem.com
    企业联系电话:0519-82895888;82899888;13306149888👤
    📞常州市怡东化工有限公司 ⚠️参考联系方式
    联系人:王先生
    电话:0519-82895888;82899888;13306149888
    手机:13306149888
    传真:0519-82891888
    邮箱:wqa@yidongchem.com
    通信地址: 江苏省常州市金坛区白龙荡化工区
    邮编: 213200
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市金坛区白龙荡化工区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis Of Aromatic Aldehydes Via 2-Aryl-N,N'-Diacyl-4-Imidazolines
    作者:Jan Bergman,Lars Renström,Birger Sjöberg |发布日期:1980.1
    摘要:Diacylimidazolium Ions Yield Adducts With Aromatic Compounds. Thus The N,N'-Diacetylimidazolium Ion And Indole Gives 1,3-Diacetyl-2-(3-Indolyl)-4-Imidazoline. Less Reactive Substrates Such As Thiophene, Anisole And 1,3-Dimethylbenzene Fail To React With This Reagent But Do Form Adducts (E.G. 1,3-Bis-(Trifluoroacetyl)-2-(2-Thienyl)-4-Imidazoline) With An Imidazole/trifluoroacetic Anhydride Reagent.

    合成参考文献


    参考文献:10.1107/s1600536811007148
    摘要:Zheng L, Hu F, Zeng XC, Li KP. rac-Dimethyl 2-(1H-pyrrole-2-carboxamido)butanedioate. Acta Crystallogr E Struct Rep Online. 2011 Mar 02;67(4):o752. doi: 10.1107/s1600536811007148.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知